LONDON (dpa-AFX) - AstraZeneca (AZN, AZN.L, ZEG.DE, AZN.ST) and Daiichi Sankyo's (4568.T) Enhertu has been recommended for approval in the European Union by CHMP as a monotherapy for the adjuvant ...
AstraZeneca: CHMP Recommends Enhertu For Approval In The EU
Source: Finanznachrichten.de
Read Full Story →
